AlloVir has been reeling ever since a trio of phase 3 trial failures last year led the company to shed almost all of its staff. | AlloVir has been reeling after a trio of phase 3 trial failures last ...

Glassdoor, Payscale, or more specifically BioPharmGuy (to look through a large variety of job offers similar to yours) are ...

The fundraise for Pathos AI, established by Eric Lefkofsky and Ryan Fukushima, pushes its valuation to $600 million.

Discover the major biotech partnerships, collaborations, and mergers and acquisitions that made headlines in October 2024.

Sage Therapeutics’ latest attempt to shrink its pipeline and workforce will see a third of the biotech’s employees ... and stronger company.” The top team wasn’t immune to those layoffs ...

Spero Therapeutics Inc. is pulling the plug on a lung disease drug trial and reducing its workforce by 39%. The Cambridge ...

Commissions do not affect our editors' opinions or evaluations. Biotech stocks are not for the faint of heart. These highly volatile equities can see stomach-churning price swings, driven by how ...

Clark University in Worcester has opened a new biotechnology research laboratory after one of ... “This grant money has been truly transformative for our research team,” Professor Donald Spratt, the ...

Mosaic Biosciences Inc., a Boulder drug-discovery company that provides protein and antibody therapeutics research to its biotech, biopharma, and academic partners, has added to its executive ...

Developed in exclusive collaboration with Hypatia, led by former Google engineer David Gordon, the asset leverages AI language.

A group called the Two Frontiers Project (2FP) — funded by biotech company Seed Health ... and increased acidification of oceans and soils” The team hopes to discover microbes inside ...